カテゴリ： 世界, 医療/バイオ, Market Monitor Global

片頭痛治療薬のグローバル市場展望 2023年-2029年：非ステロイド性抗炎症薬、アセトアミノフェン、トリプタン、その他

■ 英語タイトル：Migraine Medication Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14428）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14428
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：107
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[片頭痛治療薬のグローバル市場展望 2023年-2029年：非ステロイド性抗炎症薬、アセトアミノフェン、トリプタン、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の片頭痛治療薬市場規模と予測を収録しています。・世界の片頭痛治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の片頭痛治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の片頭痛治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「非ステロイド性抗炎症薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

片頭痛治療薬のグローバル主要企業は、GSK、 Teva、 Pfizer、 Amgen、 Viatris、 Allergan、 Grunenthal、 Eli Lilly、 Johnson & Johnson、 Bayer、 Haleon、 Tongde Pharmacy、 Huazhong Pharmaceutical、 Weisen Pharmaceutical、 DIAO GROUP、 Jiheng Pharmaceutical、 Dirui Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、片頭痛治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の片頭痛治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の片頭痛治療薬市場：タイプ別市場シェア、2022年
・非ステロイド性抗炎症薬、アセトアミノフェン、トリプタン、その他

世界の片頭痛治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の片頭痛治療薬市場：用途別市場シェア、2022年
・ドラッグストア、病院、その他

世界の片頭痛治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の片頭痛治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における片頭痛治療薬のグローバル売上、2018年-2023年
・主要企業における片頭痛治療薬のグローバル売上シェア、2022年
・主要企業における片頭痛治療薬のグローバル販売量、2018年-2023年
・主要企業における片頭痛治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GSK、 Teva、 Pfizer、 Amgen、 Viatris、 Allergan、 Grunenthal、 Eli Lilly、 Johnson & Johnson、 Bayer、 Haleon、 Tongde Pharmacy、 Huazhong Pharmaceutical、 Weisen Pharmaceutical、 DIAO GROUP、 Jiheng Pharmaceutical、 Dirui Pharmaceutical

*************************************************************

・調査・分析レポートの概要
片頭痛治療薬市場の定義
市場セグメント
世界の片頭痛治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の片頭痛治療薬市場規模
世界の片頭痛治療薬市場規模：2022年 VS 2029年
世界の片頭痛治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの片頭痛治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の片頭痛治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：非ステロイド性抗炎症薬、アセトアミノフェン、トリプタン、その他
片頭痛治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：ドラッグストア、病院、その他
片頭痛治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別片頭痛治療薬市場規模 2022年と2029年
地域別片頭痛治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GSK、 Teva、 Pfizer、 Amgen、 Viatris、 Allergan、 Grunenthal、 Eli Lilly、 Johnson & Johnson、 Bayer、 Haleon、 Tongde Pharmacy、 Huazhong Pharmaceutical、 Weisen Pharmaceutical、 DIAO GROUP、 Jiheng Pharmaceutical、 Dirui Pharmaceutical
...

This research report provides a comprehensive analysis of the Migraine Medication market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Migraine Medication market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Migraine Medication, challenges faced by the industry, and potential opportunities for market players.
The global Migraine Medication market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Migraine Medication market presents opportunities for various stakeholders, including Drug Stores, Hospitals. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Migraine Medication market. Additionally, the growing consumer demand present avenues for market expansion.
The global Migraine Medication market was valued at US$ 5576.1 million in 2022 and is projected to reach US$ 6985.2 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
One of the primary market drivers for migraine medication is the high prevalence of headaches and migraines among the global population. Headaches are one of the most common medical complaints, affecting a significant number of individuals across different age groups and demographics. Migraines, in particular, can be debilitating and significantly impact a person’s quality of life, leading to a higher demand for effective headache medications. Additionally, the increasing awareness and understanding of headaches and migraines have contributed to the growth of the headache medicine market. As people become more informed about these conditions and their treatment options, they are more likely to seek medical help and utilize headache medications.
Key Features:
The research report on the Migraine Medication market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Migraine Medication market.
Market Overview: The report provides a comprehensive overview of the Migraine Medication market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., NSAIDs, Acetaminophen), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Migraine Medication market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Migraine Medication market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Migraine Medication market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Migraine Medication market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Migraine Medication market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Migraine Medication market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Migraine Medication, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Migraine Medication market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Migraine Medication market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
NSAIDs
Acetaminophen
Triptans
Others
Market segment by Application
Drug Stores
Hospitals
Others
Global Migraine Medication Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
GSK
Teva
Pfizer
Amgen
Viatris
Allergan
Grunenthal
Eli Lilly
Johnson & Johnson
Bayer
Haleon
Tongde Pharmacy
Huazhong Pharmaceutical
Weisen Pharmaceutical
DIAO GROUP
Jiheng Pharmaceutical
Dirui Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Migraine Medication, market overview.
Chapter 2: Global Migraine Medication market size in revenue.
Chapter 3: Detailed analysis of Migraine Medication company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Migraine Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Migraine Medication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Migraine Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Migraine Medication Overall Market Size
2.1 Global Migraine Medication Market Size: 2022 VS 2029
2.2 Global Migraine Medication Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Migraine Medication Players in Global Market
3.2 Top Global Migraine Medication Companies Ranked by Revenue
3.3 Global Migraine Medication Revenue by Companies
3.4 Top 3 and Top 5 Migraine Medication Companies in Global Market, by Revenue in 2022
3.5 Global Companies Migraine Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Migraine Medication Players in Global Market
3.6.1 List of Global Tier 1 Migraine Medication Companies
3.6.2 List of Global Tier 2 and Tier 3 Migraine Medication Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Migraine Medication Market Size Markets, 2022 & 2029
4.1.2 NSAIDs
4.1.3 Acetaminophen
4.1.4 Triptans
4.1.5 Others
4.2 By Type – Global Migraine Medication Revenue & Forecasts
4.2.1 By Type – Global Migraine Medication Revenue, 2018-2023
4.2.2 By Type – Global Migraine Medication Revenue, 2024-2029
4.2.3 By Type – Global Migraine Medication Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Migraine Medication Market Size, 2022 & 2029
5.1.2 Drug Stores
5.1.3 Hospitals
5.1.4 Others
5.2 By Application – Global Migraine Medication Revenue & Forecasts
5.2.1 By Application – Global Migraine Medication Revenue, 2018-2023
5.2.2 By Application – Global Migraine Medication Revenue, 2024-2029
5.2.3 By Application – Global Migraine Medication Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Migraine Medication Market Size, 2022 & 2029
6.2 By Region – Global Migraine Medication Revenue & Forecasts
6.2.1 By Region – Global Migraine Medication Revenue, 2018-2023
6.2.2 By Region – Global Migraine Medication Revenue, 2024-2029
6.2.3 By Region – Global Migraine Medication Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Migraine Medication Revenue, 2018-2029
6.3.2 US Migraine Medication Market Size, 2018-2029
6.3.3 Canada Migraine Medication Market Size, 2018-2029
6.3.4 Mexico Migraine Medication Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Migraine Medication Revenue, 2018-2029
6.4.2 Germany Migraine Medication Market Size, 2018-2029
6.4.3 France Migraine Medication Market Size, 2018-2029
6.4.4 U.K. Migraine Medication Market Size, 2018-2029
6.4.5 Italy Migraine Medication Market Size, 2018-2029
6.4.6 Russia Migraine Medication Market Size, 2018-2029
6.4.7 Nordic Countries Migraine Medication Market Size, 2018-2029
6.4.8 Benelux Migraine Medication Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Migraine Medication Revenue, 2018-2029
6.5.2 China Migraine Medication Market Size, 2018-2029
6.5.3 Japan Migraine Medication Market Size, 2018-2029
6.5.4 South Korea Migraine Medication Market Size, 2018-2029
6.5.5 Southeast Asia Migraine Medication Market Size, 2018-2029
6.5.6 India Migraine Medication Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Migraine Medication Revenue, 2018-2029
6.6.2 Brazil Migraine Medication Market Size, 2018-2029
6.6.3 Argentina Migraine Medication Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Migraine Medication Revenue, 2018-2029
6.7.2 Turkey Migraine Medication Market Size, 2018-2029
6.7.3 Israel Migraine Medication Market Size, 2018-2029
6.7.4 Saudi Arabia Migraine Medication Market Size, 2018-2029
6.7.5 UAE Migraine Medication Market Size, 2018-2029
7 Migraine Medication Companies Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Migraine Medication Major Product Offerings
7.1.4 GSK Migraine Medication Revenue in Global Market (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Teva
7.2.1 Teva Company Summary
7.2.2 Teva Business Overview
7.2.3 Teva Migraine Medication Major Product Offerings
7.2.4 Teva Migraine Medication Revenue in Global Market (2018-2023)
7.2.5 Teva Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Migraine Medication Major Product Offerings
7.3.4 Pfizer Migraine Medication Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Amgen
7.4.1 Amgen Company Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Migraine Medication Major Product Offerings
7.4.4 Amgen Migraine Medication Revenue in Global Market (2018-2023)
7.4.5 Amgen Key News & Latest Developments
7.5 Viatris
7.5.1 Viatris Company Summary
7.5.2 Viatris Business Overview
7.5.3 Viatris Migraine Medication Major Product Offerings
7.5.4 Viatris Migraine Medication Revenue in Global Market (2018-2023)
7.5.5 Viatris Key News & Latest Developments
7.6 Allergan
7.6.1 Allergan Company Summary
7.6.2 Allergan Business Overview
7.6.3 Allergan Migraine Medication Major Product Offerings
7.6.4 Allergan Migraine Medication Revenue in Global Market (2018-2023)
7.6.5 Allergan Key News & Latest Developments
7.7 Grunenthal
7.7.1 Grunenthal Company Summary
7.7.2 Grunenthal Business Overview
7.7.3 Grunenthal Migraine Medication Major Product Offerings
7.7.4 Grunenthal Migraine Medication Revenue in Global Market (2018-2023)
7.7.5 Grunenthal Key News & Latest Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Company Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Migraine Medication Major Product Offerings
7.8.4 Eli Lilly Migraine Medication Revenue in Global Market (2018-2023)
7.8.5 Eli Lilly Key News & Latest Developments
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Company Summary
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Migraine Medication Major Product Offerings
7.9.4 Johnson & Johnson Migraine Medication Revenue in Global Market (2018-2023)
7.9.5 Johnson & Johnson Key News & Latest Developments
7.10 Bayer
7.10.1 Bayer Company Summary
7.10.2 Bayer Business Overview
7.10.3 Bayer Migraine Medication Major Product Offerings
7.10.4 Bayer Migraine Medication Revenue in Global Market (2018-2023)
7.10.5 Bayer Key News & Latest Developments
7.11 Haleon
7.11.1 Haleon Company Summary
7.11.2 Haleon Business Overview
7.11.3 Haleon Migraine Medication Major Product Offerings
7.11.4 Haleon Migraine Medication Revenue in Global Market (2018-2023)
7.11.5 Haleon Key News & Latest Developments
7.12 Tongde Pharmacy
7.12.1 Tongde Pharmacy Company Summary
7.12.2 Tongde Pharmacy Business Overview
7.12.3 Tongde Pharmacy Migraine Medication Major Product Offerings
7.12.4 Tongde Pharmacy Migraine Medication Revenue in Global Market (2018-2023)
7.12.5 Tongde Pharmacy Key News & Latest Developments
7.13 Huazhong Pharmaceutical
7.13.1 Huazhong Pharmaceutical Company Summary
7.13.2 Huazhong Pharmaceutical Business Overview
7.13.3 Huazhong Pharmaceutical Migraine Medication Major Product Offerings
7.13.4 Huazhong Pharmaceutical Migraine Medication Revenue in Global Market (2018-2023)
7.13.5 Huazhong Pharmaceutical Key News & Latest Developments
7.14 Weisen Pharmaceutical
7.14.1 Weisen Pharmaceutical Company Summary
7.14.2 Weisen Pharmaceutical Business Overview
7.14.3 Weisen Pharmaceutical Migraine Medication Major Product Offerings
7.14.4 Weisen Pharmaceutical Migraine Medication Revenue in Global Market (2018-2023)
7.14.5 Weisen Pharmaceutical Key News & Latest Developments
7.15 DIAO GROUP
7.15.1 DIAO GROUP Company Summary
7.15.2 DIAO GROUP Business Overview
7.15.3 DIAO GROUP Migraine Medication Major Product Offerings
7.15.4 DIAO GROUP Migraine Medication Revenue in Global Market (2018-2023)
7.15.5 DIAO GROUP Key News & Latest Developments
7.16 Jiheng Pharmaceutical
7.16.1 Jiheng Pharmaceutical Company Summary
7.16.2 Jiheng Pharmaceutical Business Overview
7.16.3 Jiheng Pharmaceutical Migraine Medication Major Product Offerings
7.16.4 Jiheng Pharmaceutical Migraine Medication Revenue in Global Market (2018-2023)
7.16.5 Jiheng Pharmaceutical Key News & Latest Developments
7.17 Dirui Pharmaceutical
7.17.1 Dirui Pharmaceutical Company Summary
7.17.2 Dirui Pharmaceutical Business Overview
7.17.3 Dirui Pharmaceutical Migraine Medication Major Product Offerings
7.17.4 Dirui Pharmaceutical Migraine Medication Revenue in Global Market (2018-2023)
7.17.5 Dirui Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Migraine Medication Market Opportunities & Trends in Global Market
Table 2. Migraine Medication Market Drivers in Global Market
Table 3. Migraine Medication Market Restraints in Global Market
Table 4. Key Players of Migraine Medication in Global Market
Table 5. Top Migraine Medication Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Migraine Medication Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Migraine Medication Revenue Share by Companies, 2018-2023
Table 8. Global Companies Migraine Medication Product Type
Table 9. List of Global Tier 1 Migraine Medication Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Migraine Medication Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Migraine Medication Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Migraine Medication Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Migraine Medication Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Migraine Medication Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Migraine Medication Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Migraine Medication Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Migraine Medication Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Migraine Medication Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Migraine Medication Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Migraine Medication Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Migraine Medication Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Migraine Medication Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Migraine Medication Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Migraine Medication Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Migraine Medication Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Migraine Medication Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Migraine Medication Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Migraine Medication Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Migraine Medication Revenue, (US$, Mn), 2024-2029
Table 30. GSK Company Summary
Table 31. GSK Migraine Medication Product Offerings
Table 32. GSK Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 33. GSK Key News & Latest Developments
Table 34. Teva Company Summary
Table 35. Teva Migraine Medication Product Offerings
Table 36. Teva Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Migraine Medication Product Offerings
Table 40. Pfizer Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. Amgen Company Summary
Table 43. Amgen Migraine Medication Product Offerings
Table 44. Amgen Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 45. Amgen Key News & Latest Developments
Table 46. Viatris Company Summary
Table 47. Viatris Migraine Medication Product Offerings
Table 48. Viatris Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 49. Viatris Key News & Latest Developments
Table 50. Allergan Company Summary
Table 51. Allergan Migraine Medication Product Offerings
Table 52. Allergan Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 53. Allergan Key News & Latest Developments
Table 54. Grunenthal Company Summary
Table 55. Grunenthal Migraine Medication Product Offerings
Table 56. Grunenthal Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 57. Grunenthal Key News & Latest Developments
Table 58. Eli Lilly Company Summary
Table 59. Eli Lilly Migraine Medication Product Offerings
Table 60. Eli Lilly Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 61. Eli Lilly Key News & Latest Developments
Table 62. Johnson & Johnson Company Summary
Table 63. Johnson & Johnson Migraine Medication Product Offerings
Table 64. Johnson & Johnson Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 65. Johnson & Johnson Key News & Latest Developments
Table 66. Bayer Company Summary
Table 67. Bayer Migraine Medication Product Offerings
Table 68. Bayer Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 69. Bayer Key News & Latest Developments
Table 70. Haleon Company Summary
Table 71. Haleon Migraine Medication Product Offerings
Table 72. Haleon Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 73. Haleon Key News & Latest Developments
Table 74. Tongde Pharmacy Company Summary
Table 75. Tongde Pharmacy Migraine Medication Product Offerings
Table 76. Tongde Pharmacy Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 77. Tongde Pharmacy Key News & Latest Developments
Table 78. Huazhong Pharmaceutical Company Summary
Table 79. Huazhong Pharmaceutical Migraine Medication Product Offerings
Table 80. Huazhong Pharmaceutical Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 81. Huazhong Pharmaceutical Key News & Latest Developments
Table 82. Weisen Pharmaceutical Company Summary
Table 83. Weisen Pharmaceutical Migraine Medication Product Offerings
Table 84. Weisen Pharmaceutical Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 85. Weisen Pharmaceutical Key News & Latest Developments
Table 86. DIAO GROUP Company Summary
Table 87. DIAO GROUP Migraine Medication Product Offerings
Table 88. DIAO GROUP Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 89. DIAO GROUP Key News & Latest Developments
Table 90. Jiheng Pharmaceutical Company Summary
Table 91. Jiheng Pharmaceutical Migraine Medication Product Offerings
Table 92. Jiheng Pharmaceutical Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 93. Jiheng Pharmaceutical Key News & Latest Developments
Table 94. Dirui Pharmaceutical Company Summary
Table 95. Dirui Pharmaceutical Migraine Medication Product Offerings
Table 96. Dirui Pharmaceutical Migraine Medication Revenue (US$, Mn) & (2018-2023)
Table 97. Dirui Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Migraine Medication Segment by Type in 2022
Figure 2. Migraine Medication Segment by Application in 2022
Figure 3. Global Migraine Medication Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Migraine Medication Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Migraine Medication Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Migraine Medication Revenue in 2022
Figure 8. By Type - Global Migraine Medication Revenue Market Share, 2018-2029
Figure 9. By Application - Global Migraine Medication Revenue Market Share, 2018-2029
Figure 10. By Type - Global Migraine Medication Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Migraine Medication Revenue Market Share, 2018-2029
Figure 12. By Application - Global Migraine Medication Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Migraine Medication Revenue Market Share, 2018-2029
Figure 14. By Region - Global Migraine Medication Revenue Market Share, 2018-2029
Figure 15. By Country - North America Migraine Medication Revenue Market Share, 2018-2029
Figure 16. US Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Migraine Medication Revenue Market Share, 2018-2029
Figure 20. Germany Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 21. France Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Migraine Medication Revenue Market Share, 2018-2029
Figure 28. China Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 32. India Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Migraine Medication Revenue Market Share, 2018-2029
Figure 34. Brazil Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Migraine Medication Revenue Market Share, 2018-2029
Figure 37. Turkey Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Migraine Medication Revenue, (US$, Mn), 2018-2029
Figure 41. GSK Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Amgen Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Viatris Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Allergan Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Grunenthal Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eli Lilly Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Johnson & Johnson Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bayer Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Haleon Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Tongde Pharmacy Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Huazhong Pharmaceutical Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Weisen Pharmaceutical Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. DIAO GROUP Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Jiheng Pharmaceutical Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Dirui Pharmaceutical Migraine Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • OTC片頭痛薬のグローバル市場展望 2023年-2029年：NSAIDs、アセトアミノフェン、その他
  • 歯科用NSAID（非ステロイド性抗炎症薬）のグローバル市場展望 2023年-2029年：注射型、経口型、その他
  • 処方片頭痛薬のグローバル市場展望 2023年-2029年：スマトリプタン、リザトリプタン、その他
  • コウニス症候群治療の世界市場2023年：β-ラクタム系抗生物質、非ステロイド性抗炎症薬、ロクロニウム、その他
  • 片頭痛処方薬のグローバル市場展望 2023年-2029年：スマトリプタン、リザトリプタン、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14428 )"片頭痛治療薬のグローバル市場展望 2023年-2029年：非ステロイド性抗炎症薬、アセトアミノフェン、トリプタン、その他" (英文：Migraine Medication Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。